603669 Lionco Pharmaceutical Group
- 6.08
- +0.04+0.66%
Lionco Pharmaceutical Group News
Lingkang Pharmaceutical: Announcement on subsidiary cefuroxime sodium for injection passing the generic drug consistency evaluation
Lingkang Pharmaceutical Group Co., Ltd. Investor Relations Activity Record Form for November 3, 2024
Announcement of the Resolution of the 19th Meeting of the Fourth Board of Directors.
Special report on the annual deposit and use of funds raised in the first half of 2024.
Announcement of Resolution of the Fifteenth Meeting of the Fourth Supervisor Board.
Announcement on the completion of guarantee and trust registration for the part of the company's shares held by the controlling shareholder in the proposed non-public issuance of exchangeable corporate bonds.
Announcement on the holder of the pledged shares and trust registration for the non-public issuance of convertible corporate bonds by the controlling shareholder.
CITIC Securities' opinion on the verification of Lionco Pharmaceutical Group's use of some idle raised funds to temporarily supplement working capital.
Announcement regarding the use of some idle raised funds to temporarily supplement working capital.
Announcement of Resolutions of the 15th Meeting of the Fourth Board of Directors
Announcement on holding the performance briefing for the year 2023 and first quarter of 2024.
Special instructions on the regulatory work letter of information disclosure about Lionco Pharmaceutical Group Co., Ltd.'s 2023 annual report from China Audit Crowd Environmental Accounting Firm.
CITIC Securities Co., Ltd.'s verification opinion on related issues of the information disclosure regulatory letter on Lionco Pharmaceutical Group Co., Ltd.'s 2023 annual report
Announcement of Resolutions of the 13th Meeting of the Fourth Board of Directors
Independent Director's 2023 Debriefing Report - Pan Ziqiang
Lingkang Pharmaceutical Group Co., Ltd. 2023 Accounting Firm Performance Assessment Report
Special inspection report on the 2023 operating income deduction status table of Lingkang Pharmaceutical Group Co., Ltd.
Announcement of Resolutions of the 11th Meeting of the Fourth Board of Directors
Working Rules for Independent Directors (Revised in April 2024)
Special report on the annual storage and use of raised funds
Analysis
Price Target
No Data
No Data